ResearchMoz

United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020

GlobalData
Published Date » 2014-05-09
No. Of Pages » 149
   
 "United States Cardiovascular Monitoring and Diagnostic Devices Market Outlook to 2020", provides key market data on the United States Cardiovascular Monitoring and Diagnostic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems and Holter Monitoring Systems. 
   
 The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiovascular Monitoring and Diagnostic Devices market...

Table of content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 What Is This Report About? 9
2.2 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation 9
2.3 Definitions of Markets Covered in the Report 10

3 Cardiovascular Monitoring and Diagnostic Devices Market, United States 12
3.1 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2005-2012 12
3.2 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), 2012-2020 14
3.3 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2005-2012 16
3.4 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), 2012-2020 18
3.5 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), 2005-2020 20
3.6 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), 2011-2012 22
3.7 Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), 2011-2012 23

4 Overview of Key Companies in United States, Cardiovascular Monitoring and Diagnostic Devices Market 25
4.1 GE Healthcare 25
4.1.1 Company Overview 25
4.2 Philips Healthcare 25
4.2.1 Company Overview 25
4.3 CareFusion Corporation 25
4.3.1 Company Overview 25
4.4 Welch Allyn Inc. 26
4.4.1 Company Overview 26
4.5 OSI Systems, Inc. 26
4.5.1 Company Overview 26
4.6 Opto Circuits India Limited 26
4.6.1 Company Overview 26
4.7 Schiller AG 27
4.7.1 Company Overview 27
4.8 Mortara Instrument, Inc. 27
4.8.1 Company Overview 27
4.9 Nihon Kohden Corporation 27
4.9.1 Company Overview 27
4.10 Fukuda Denshi Co., Ltd. 28
4.10.1 Company Overview 28

5 Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 29

6 Financial Deals Landscape 31
6.1 Acquisition 31
6.1.1 Digirad Acquires Telerhythmics For US$4 Million 31
6.1.2 St. Jude Medical To Acquire CardioMEMS 33
6.2 Asset Transactions 35
6.2.1 BioTelemetry Completes Acquisition Of Cardiac Patient Services Business From Biomedical Systems For US$8.6 Million 35
6.2.2 Mortara Instrument To Acquire Diagnostic Cardiology Product Line Of Cardiac Science For US$21 Million 37
6.3 Debt Offerings 39
6.3.1 Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 39
6.4 Equity Offerings 41
6.4.1 CardioDx Postpones IPO 41
6.4.2 Bioheart Completes Private Placement Of Shares 43
6.4.3 Bioheart Announces Private Placement Of Shares For US$2 Million 44
6.5 Partnerships 45
6.5.1 Millar Instruments Enters Into Distribution Agreement With CD Leycom 45
6.5.2 Cardionet, Imec, And Delta Enter Into Agreement To Develop Cardiac Monitoring Products 46
6.5.3 Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 47
6.5.4 Infraredx Enters Into Co-Development Agreement With Philips 48
6.5.5 Lifewatch Services Enters Into Technology Integration Agreement With Perminova 49
6.5.6 Compumed Entres Into Technology Integration Agreement With GE Healthcare 50
6.6 Private Equity 51
6.6.1 ICU Medical Drops The Sale Of The Company 51
6.6.2 Tenex Capital Acquires Roscoe Medical 53
6.6.3 HealthEdge Investment Fund II Acquires Majority Stake In LifeSync, Maker Of Wireless Electrocardiogram Data Communications System 54
6.7 Venture Financing 55
6.7.1 InfoBionic Raises US$17 Million In First Tranche Of Series B Financing 55
6.7.2 Cardiox Raises US$3.2 Million In Venture Financing 57
6.7.3 Cheetah Medical Raises US$9 Million In Venture Financing 58
6.7.4 Cardiac Insight Raises US$2 Million In Venture Financing 60
6.7.5 Eso-Technologies Raises US$0.6 Million In Series A Financing 61
6.7.6 Nipro Invests US$25 Million In Infraredx 63
6.7.7 Rijuven Raises US$0.3 Million In Venture Financing 65
6.7.8 Cardiac Insight Raises US$1.3 Million In Venture Financing 66
6.7.9 Topera Raises US$25 Million In Series C Financing 67
6.7.10 iRhythm Technologies Raises US$16 Million In Series D Financing 68
6.7.11 Cheetah Medical Raises US$14.4 Million In Extended Series C Financing 70
6.7.12 Endotronix Raises US$1.2 Million In Venture Financing 71
6.7.13 Cardiox Raises US$9.4 Million In Venture Financing 72
6.7.14 Cardiox Raises US$0.4 Million In Venture Financing 73
6.7.15 Angel Medical Systems Raises US$27.5 Million In Initial Closing Of Venture Financing Round 74
6.7.16 iRhythm Technologies Raises US$1.5 Million In Venture Financing 75
6.7.17 iRhythm Technologies Raises US$3.5 Million In Venture Financing 76
6.7.18 Rijuven Raises US$0.5 Million In Venture Financing 78
6.7.19 Aviir Raises US$5 Million In Venture Financing 79
6.7.20 Cardiac Insight Raises US$0.3 Million In Venture Financing 81
6.7.21 Inovise Medical Raises US$0.4 Million In Venture Financing 82
6.7.22 Rijuven Raises US$0.9 Million In Venture Financing 83

7 Recent Developments 84
7.1 Corporate Communications 84
7.1.1 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director 84
7.1.2 Feb 12, 2014: ICU Medical Names Vivek Jain as New Chief Executive Officer and Chairman 84
7.1.3 Jan 31, 2014: AMAG Pharmaceuticals Announces Issuance of New U.S. Patent for Ferumoxytol 85
7.1.4 Dec 19, 2013: Bioheart Reports Update on CEO 85
7.1.5 Nov 22, 2013: Voyage Care Acquires Ingleby Care 85
7.1.6 Nov 18, 2013: Bioheart's President/CEO Mike Tomas Named Chair of the eMerge Innovate Advisory Board of eMerge Americas 86
7.1.7 Oct 21, 2013: ICU Medical Announces Management Transition 87
7.1.8 Sep 23, 2013: Bioheart Boosts Team with Regulatory, Finance and Administrative Expertise Three New Key Positions Added 88
7.1.9 Sep 19, 2013: Atherotech Diagnostics Lab Bolsters Research Efforts with Addition of Abate as Chief Clinical Officer 88
7.1.10 Sep 13, 2013: Arrhythmia Research Technology Announces Resignation of CFO and Appointment of New Principal Financial Officer 89
7.1.11 Aug 28, 2013: Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc. 89
7.1.12 Aug 01, 2013: CardioNet Holding Company Structure Effective 90
7.1.13 Jul 23, 2013: Vincent Caponi Joins Welch Allyn Board of Directors 90
7.1.14 Jun 04, 2013: Cheetah Medical Appoints Chris Hutchison As CEO 91
7.2 Financial Announcements 91
7.2.1 Apr 16, 2014: Osteoarthritis Study shows ActiPatch Therapy Significantly Relieves Knee Pain 91
7.2.2 Mar 27, 2014: Vasomedical Announces Financial Results for Fourth Quarter and Full Year for 2013 93
7.2.3 Feb 12, 2014: ICU Medical Announces Fourth Quarter and Fiscal Year 2013 Results 95
7.2.4 Jan 20, 2014: Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Associations Journal, Circulation 96
7.2.5 Nov 19, 2013: Arrhythmia Research Technology Announces Third Quarter 2013 Results 97
7.2.6 Nov 14, 2013: Vasomedical Recorded 33% Year-over-year Growth in Revenue for the Third Quarter of 2013 98
7.2.7 Nov 05, 2013: Vasomedical to Report Third Quarter 2013 Results on November 14, 2013 99
7.2.8 Nov 05, 2013: BioTelemetry Reports Third Quarter 2013 Financial Results 99
7.2.9 Oct 29, 2013: BioTelemetry to Release Third Quarter 2013 Earnings Results on November 5, 2013 100
7.2.10 Oct 21, 2013: ICU Medical Reports Third Quarter 2013 Results 101
7.2.11 Oct 16, 2013: ICU Medical Announces Time of Third Quarter 2013 Earnings Call 102
7.2.12 Oct 08, 2013: Arrhythmia Research Technology Announces Second Quarter 2013 Results 102
7.2.13 Oct 02, 2013: Arrhythmia Research Technology Announces Updated Preliminary Second Quarter Results 103
7.2.14 Aug 20, 2013: First Databank Acquires Design Clinicals, Medication Reconciliation Solutions Provider 104
7.2.15 Aug 20, 2013: Arrhythmia Research Technology, Inc. Announces Delay in Finalizing Second Quarter Results 106
7.2.16 Aug 13, 2013: Vasomedical Announces Financial Results for the Second Quarter of 2013 106
7.2.17 Aug 06, 2013: Vasomedical to Report Second Quarter 2013 Results on August 13, 2013 107
7.2.18 Jul 30, 2013: CardioNet Reports Second Quarter 2013 Financial Results 108
7.2.19 Jul 23, 2013: CardioNet to Release Second Quarter 2013 Earnings Results on July 30, 2013 109
7.2.20 Jul 18, 2013: ICU Medical Reports Second Quarter 2013 Results 109
7.2.21 Jun 28, 2013: Arrhythmia Research Technology, Inc. Announces First Quarter 2013 Results 110
7.2.22 Jun 17, 2013: Takeda Announces Availability Of Nesina In US Pharmacies 111
7.2.23 Jun 03, 2013: Arrhythmia Reports Revenue Of $20.6m In 2012 112
7.2.24 May 15, 2013: Vasomedical Reports Revenue Of $7.3m In Q1 2013 113
7.2.25 May 09, 2013: Bioheart Reports Q1 2013 Results 114
7.2.26 May 07, 2013: PLC Systems Presents Clinical Data Of RenalGuard System At 60th International Conference Of Israel Heart Society 115
7.3 Government and Public Interest 117
7.3.1 Jan 06, 2014: ICU Medical to Present at the 32nd Annual J.P. Morgan Healthcare Conference 117
7.3.2 Jan 02, 2014: Topera to Present at the 32nd Annual J.P. Morgan Healthcare Conference 117
7.3.3 Dec 31, 2013: Bioheart to Present at Vail Symposium's Winter Program on Cell Therapy 117
7.3.4 Dec 02, 2013: ZOLL Summit 2014 Call for Presentations 117
7.3.5 Nov 25, 2013: Topera to Present at the 25th Annual Piper Jaffray Health Conference 118
7.3.6 Nov 21, 2013: ICU Medical to Present at the Piper Jaffray 25th Annual Healthcare Conference 118
7.3.7 Oct 23, 2013: Additional dedicated trainer hospital established in the USA 118
7.3.8 Aug 09, 2013: IMRIS CEO Jay D. Miller to present at Canaccord Genuity 33rd Annual Global Growth Conference 118
7.4 Legal And Regulatory 119
7.4.1 Apr 17, 2014: Boston Heart Granted New York Laboratory Permit for Diagnostic Testing 119
7.5 Other Significant Developments 119
7.5.1 Feb 24, 2014: AliveCor Offers Integration With Practice Fusion's Electronic Health Records Platform 119
7.5.2 Feb 20, 2014: Boston Heart Diagnostics Awarded $1.0 Million in Tax Incentives from the Massachusetts Life Sciences Center 120
7.5.3 Dec 04, 2013: BioTelemetry, Inc. Announces Reduction to Medicare Reimbursement for Remote Cardiac Monitoring Services 121
7.5.4 Dec 02, 2013: Bioheart Announces Agreement With StemMD to Provide Bioheart Therapies to Its Network 121
7.5.5 Nov 18, 2013: AliveCor transforms Heart Monitor into eHealth Service 121
7.5.6 Nov 15, 2013: Millar Appointed Exclusive US Distributor of CD Leycom INCA Pressure-Volume Loop System 122
7.5.7 Oct 25, 2013: Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East 123
7.5.8 Oct 16, 2013: Bioheart Announces Contract With African-Middle East Medical to Begin Distributing Stem Cell Products in Uganda 123
7.5.9 Oct 09, 2013: $2 Million Awarded to Sutter Health, IBM and Geisinger Health System to Study Heart Failure Prediction 123
7.5.10 Aug 23, 2013: Arrhythmia Research Technology Receives NYSE MKT LLC Exchange Compliance Notice 125
7.5.11 Jul 09, 2013: Behrman Capital Portfolio Company Atherotech Completes Recapitalization 125
7.6 Product News 125
7.6.1 Apr 16, 2014: AtCor Medical Receives Patent in USA 125
7.6.2 Mar 27, 2014: First Patients Enrolled in Medtronic Clinical Study Designed to Identify Patients at High Risk for Sudden Cardiac Arrest in Developing Countries 126
7.6.3 Mar 17, 2014: Vasomedical Announces Biox's MobiCare Wireless Patient Monitors Receives Marketing Approval in China 127
7.6.4 Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients 127
7.6.5 Jan 22, 2014: UCLA researchers develop risk calculator to predict survival in heart failure patients 128
7.6.6 Jan 06, 2014: FDA Reclassifies ECP Devices for Refractory Angina as Class II 130
7.6.7 Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine 130
7.6.8 Nov 25, 2013: Independent Multi-Center Clinical Study Shows the Use of Toperas 3D Mapping System Improved Long-Term Outcomes for Atrial Fibrillation Patients 131
7.6.9 Nov 18, 2013: AliveCor Transforms Heart Monitor into eHealth Service 132
7.6.10 Oct 07, 2013: MDxHealths Prostate Cancer Test Meets Endpoints In DOCUMENT Trial 133
7.6.11 Aug 23, 2013: AliveCor Launches New Feature to Enhance Visual Quality of ECG 135
7.6.12 May 14, 2013: iCardiac Releases StudyView Module for iClinica 4G Cardiac Safety Software Platform 135
7.7 Research And Development 136
7.7.1 Jun 04, 2013: Immunicum's Intuvax Is Registered As Brand In EU At Office for Harmonization in the Internal Market 136
7.8 Strategy And Business Planning 136
7.8.1 Nov 25, 2013: Bioheart Announces New Clinical Site in Mexico 136
7.8.2 Nov 06, 2013: Welch Allyn Establishes New Regional Headquarters, Operations Center in The Netherlands 137
7.8.3 Nov 04, 2013: Bioheart Announces Agreement With Global Stem Cell Group to Provide Bioheart Therapies and Training 138
7.8.4 Jul 25, 2013: First Injection of Dotarem in US Performed at Cincinnati Children's Hospital Medical Center 138
7.8.5 Jul 02, 2013: Apogenix Strengthens Patent Position for Apocept In Europe And Canada 139

8 Appendix 141
8.1 Research Methodology 142
8.1.1 Coverage 142
8.1.2 Secondary Research 142
8.1.3 Primary Research 143
8.1.4 Market Modeling and Forecasting 144
8.1.5 Company Share Analysis 147
8.1.6 Distribution Share Analysis 148
8.2 Expert Panel 148
8.3 GlobalData Consulting 149
8.4 Contact Us 149
8.5 Disclaimer 149

List of Tables


Table 1: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 13
Table 2: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 15
Table 3: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 17
Table 4: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 19
Table 5: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Historic, 2005-2012 20
Table 6: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Average Price ($), Forecast, 2012-2020 21
Table 7: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 22
Table 8: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 24
Table 9: Cardiovascular Monitoring and Diagnostic Devices Market Pipeline Products 29
Table 10: Digirad Acquires Telerhythmics For US$4 Million 31
Table 11: St. Jude Medical To Acquire CardioMEMS 33
Table 12: BioTelemetry Completes Acquisition Of Cardiac Patient Services Business From Biomedical Systems For US$8.6 Million 35
Table 13: Mortara Instrument To Acquire Diagnostic Cardiology Product Line Of Cardiac Science For US$21 Million 37
Table 14: Edwards Lifesciences Completes Public Offering Of Notes Due 2018 For US$600 Million 39
Table 15: CardioDx Postpones IPO 41
Table 16: Bioheart Completes Private Placement Of Shares 43
Table 17: Bioheart Announces Private Placement Of Shares For US$2 Million 44
Table 18: Millar Instruments Enters Into Distribution Agreement With CD Leycom 45
Table 19: Cardionet, Imec, And Delta Enter Into Agreement To Develop Cardiac Monitoring Products 46
Table 20: Everist Genomics Enters Into Licensing Agreement With Rutgers For Cardiovascular Disease Monitoring Sensor Technology 47
Table 21: Infraredx Enters Into Co-Development Agreement With Philips 48
Table 22: Lifewatch Services Enters Into Technology Integration Agreement With Perminova 49
Table 23: Compumed Entres Into Technology Integration Agreement With GE Healthcare 50
Table 24: ICU Medical Drops The Sale Of The Company 51
Table 25: Tenex Capital Acquires Roscoe Medical 53
Table 26: HealthEdge Investment Fund II Acquires Majority Stake In LifeSync, Maker Of Wireless Electrocardiogram Data Communications System 54
Table 27: InfoBionic Raises US$17 Million In First Tranche Of Series B Financing 55
Table 28: Cardiox Raises US$3.2 Million In Venture Financing 57
Table 29: Cheetah Medical Raises US$9 Million In Venture Financing 58
Table 30: Cardiac Insight Raises US$2 Million In Venture Financing 60
Table 31: Eso-Technologies Raises US$0.6 Million In Series A Financing 61
Table 32: Nipro Invests US$25 Million In Infraredx 63
Table 33: Rijuven Raises US$0.3 Million In Venture Financing 65
Table 34: Cardiac Insight Raises US$1.3 Million In Venture Financing 66
Table 35: Topera Raises US$25 Million In Series C Financing 67
Table 36: iRhythm Technologies Raises US$16 Million In Series D Financing 68
Table 37: Cheetah Medical Raises US$14.4 Million In Extended Series C Financing 70
Table 38: Endotronix Raises US$1.2 Million In Venture Financing 71
Table 39: Cardiox Raises US$9.4 Million In Venture Financing 72
Table 40: Cardiox Raises US$0.4 Million In Venture Financing 73
Table 41: Angel Medical Systems Raises US$27.5 Million In Initial Closing Of Venture Financing Round 74
Table 42: iRhythm Technologies Raises US$1.5 Million In Venture Financing 75
Table 43: iRhythm Technologies Raises US$3.5 Million In Venture Financing 76
Table 44: Rijuven Raises US$0.5 Million In Venture Financing 78
Table 45: Aviir Raises US$5 Million In Venture Financing 79
Table 46: Cardiac Insight Raises US$0.3 Million In Venture Financing 81
Table 47: Inovise Medical Raises US$0.4 Million In Venture Financing 82
Table 48: Rijuven Raises US$0.9 Million In Venture Financing 83
Table 49: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 144

List of Figures


Figure 1: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 12
Figure 2: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 14
Figure 3: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Historic, 2005-2012 16
Figure 4: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Volume (Units), Forecast, 2012-2020 18
Figure 5: Cardiovascular Monitoring and Diagnostic Devices Market, United States, Company Share (%), 2012 23
Figure 6: GlobalData Epidemiology-Based Forecasting Model 146
Figure 7: GlobalData Capital Equipment-Based Forecasting Model 147
Figure 8: Primary Interviews by Participant Type (%) 148

Upcoming Reports:

Poland: beer market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the beer market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the beer market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main market...
Nanosensors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
Nanosensors are biological, surgical or chemical sensory points used to convey information about nano-particle to the macroscopic world such as human observer or electrical device. Alternatively they can be defined as extremely small devices that are capable of detecting and responding to physical stimuli such as biological or chemical substances, acoustics, thermal or electromagnetic signals having dimensions in the order of one billionth of a meter. In today’s scenario nanosensors market is highly fragmented and posses a wide range of applications such as healthcare, defense,...
Clinical Diagnosis Automation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Some of the major factors which are driving the clinical diagnosis automation market include: growing number of diagnosis globally, low reimbursement rates and growing number of suppliers in the diagnostic market. Many players in the clinical diagnostics market, due to intense competition are looking to sustain in the market by gaining some competitive advantage over each other. These players are focusing on cutting down the overall cost and are putting pressure on laboratories to increase their efficiency and productivity. Automation is proving very fruitful in order to increase...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Food Imported by the U.S. Under Scanner
Nov 27, 2014  
The U.S. Food and Drug Administration and the U.S. Department of Homeland Security have joined forces to address a major issue of national security - food supply. Given the fact that 15% of the country’s food supply is being imported from overseas, it has become imperative to monitor from where the food is coming in. FDA officers recently inspected a plant in Carson, checking...
iPhone 6 Consistently Best Smartphone: Japan
Nov 27, 2014  
BCN, one of the tracking websites in Japan, has tracked the sales of multiple consumer devices on a weekly and monthly basis. Their results show that the iPhone has held the top positions in all its segments for the past three months. The months of October saw Apple’s iPhone 6 in dominion by holding the top six positions for smartphone sales. Of the 14, it held 9 places after...
Renewable Energy Supersedes Nuclear Power in Scotland
Nov 27, 2014  
Reports by BusinessGreen show that clean energy in Scotland has produced more power than coal, gas, or nuclear. This is the first time it has happened in the first half of 2014.  New industry figures will also show on Thursday, how renewable energy through hydro power plants, wind farms, and other clean technologies in Scotland provides as the single largest source of electricity...
World Cup Stadium at Qatar to be Renovated for 2022 FIFA World Cup
Nov 26, 2014  
The design for renovation of the Khalifa International Stadium will soon be unveiled by the organization that is responsible for building the infrastructure and stadiums for the 2022 FIFA World Cup Qatar. The main construction work on the stadium is being looked into by two prominent construction companies. The joint venture is between Six Construct and Midmac Contracting. Six Construct is a...
DOD Spending Low, Corps Look for More Work in Alaska
Nov 24, 2014  
Military construction across Alaska continues to decline. Government contractors expect to keep busy for the time being with work delegated by other federal agencies. The United States Army Corps of Engineers expects to have more than US$410 million worth of work available on at least 400 projects in the 2015 fiscal year. Chris Tew, the Alaska Contracting Division chief said that is...